A story of shoe shopping and resilience in adapting to ALS
When columnist Dagmar Munn's special footwear began to wear out, she went shoe shopping — which required a certain amount of resilience.| ALS News Today
When columnist Dagmar Munn's special footwear began to wear out, she went shoe shopping — which required a certain amount of resilience.| ALS News Today
This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope for the future.| ALS News Today
What columnist Dagmar Munn thought was an ALS symptom was just an impostor. "Learned nonuse" was her true problem, and she addressed it.| ALS News Today
Lindsey Shapiro is a science writer for ALS News Today with a PhD in neuroscience. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
A gene therapy to increase nerve cell connectivity worked to ease motor dysfunction in an ALS mouse model but did not prolong survival.| ALS News Today
The FDA granted conditional approval to tofersen, now Qalsody, for the treatment of ALS associated with mutations in the SOD1 gene.| ALS News Today
PrimeC slowed lung function decline and complication-free survival when treatment started early, per data from a Phase 2b ALS clinical trial.| ALS News Today
Category archive page for News.| ALS News Today
